OFF-BRAND STI571: A BUDGET-FRIENDLY CHOICE?

The emergence of off-brand imatinib represents a notable opportunity for patients battling CML and other diseases. Original brand-name imatinib, often referred to as Gleevec, carries a considerable price tag, frequently making it accessibility for some individuals. Common versions, usually manufa